95 related articles for article (PubMed ID: 27644653)
1. Clinico-Hematological Findings for Classical Hodgkin's Lymphoma: an Institutional Experience.
Sultan S; Irfan SM; Parveen S; Ali S
Asian Pac J Cancer Prev; 2016; 17(8):4009-11. PubMed ID: 27644653
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin's lymphoma in Pakistan: a clinico-epidemiological study of 658 cases at a cancer center in Lahore.
Siddiqui N; Ayub B; Badar F; Zaidi A
Asian Pac J Cancer Prev; 2006; 7(4):651-5. PubMed ID: 17250446
[TBL] [Abstract][Full Text] [Related]
3. Frequency and Pattern of Bone Marrow Infiltration in Classical Hodgkin's Lymphoma: Experience from Southern Pakistan.
Sultan S; Irfan SM; Parveen S; Haider SA; Masood M
Asian Pac J Cancer Prev; 2016; 17(4):1857-9. PubMed ID: 27221865
[TBL] [Abstract][Full Text] [Related]
4. Histopathology of Hodgkin's lymphoma.
Eberle FC; Mani H; Jaffe ES
Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
[TBL] [Abstract][Full Text] [Related]
5. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
[TBL] [Abstract][Full Text] [Related]
7. Clinico-hematological Profile of 184 Patients with Non-Hodgkin's Lymphoma: An Experience from Southern Pakistan.
Sultan S; Irfan SM; Rashid A; Parveen S; Nawaz N
Gulf J Oncolog; 2017 Sep; 1(25):11-14. PubMed ID: 29019324
[TBL] [Abstract][Full Text] [Related]
8. Nodular lymphocyte predominant Hodgkin's lymphoma.
Siddiqui N; Al-Diab AI
Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
[TBL] [Abstract][Full Text] [Related]
9. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathological study of Hodgkin's lymphoma in a cancer center in Taiwan.
Lee MY; Tan TD; Feng AC
Clin Lab Haematol; 2005 Dec; 27(6):379-83. PubMed ID: 16307539
[TBL] [Abstract][Full Text] [Related]
13. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
14. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
15. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
[TBL] [Abstract][Full Text] [Related]
16. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease, follicular non-Hodgkin's lymphoma and a high grade B cell non-Hodgkin's lymphoma in the same patient.
Gibbs SJ; Tobias JS
Leuk Lymphoma; 1995 Jun; 18(1-2):185-7. PubMed ID: 8580824
[TBL] [Abstract][Full Text] [Related]
18. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Spectrum of Hodgkin's and Non-Hodgkin's Lymphoma: A Tertiary Care Cancer Hospital Study in Pakistan.
Aslam W; Habib M; Aziz S
Cureus; 2022 Jun; 14(6):e25620. PubMed ID: 35784957
[TBL] [Abstract][Full Text] [Related]
20. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]